Singapore markets open in 5 hours 28 minutes

LifeStance Health Group, Inc. (LFST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.36-0.09 (-1.21%)
As of 03:32PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.80B
Enterprise value 2.91B
Trailing P/E N/A
Forward P/E 156.25
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.35
Price/book (mrq)1.83
Enterprise value/revenue 3.75
Enterprise value/EBITDA -9.53

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-50.60%
S&P500 52-week change 3-16.88%
52-week high 315.49
52-week low 34.77
50-day moving average 37.16
200-day moving average 37.97

Share statistics

Avg vol (3-month) 3785.88k
Avg vol (10-day) 31.06M
Shares outstanding 5376.18M
Implied shares outstanding 6N/A
Float 872.19M
% held by insiders 115.44%
% held by institutions 183.93%
Shares short (30 Aug 2022) 48.73M
Short ratio (30 Aug 2022) 418.48
Short % of float (30 Aug 2022) 411.88%
Short % of shares outstanding (30 Aug 2022) 42.32%
Shares short (prior month 28 Jul 2022) 49.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -46.31%
Operating margin (ttm)-46.85%

Management effectiveness

Return on assets (ttm)-11.71%
Return on equity (ttm)-23.38%

Income statement

Revenue (ttm)776.45M
Revenue per share (ttm)2.22
Quarterly revenue growth (yoy)30.50%
Gross profit (ttm)233.23M
EBITDA -302.19M
Net income avi to common (ttm)-359.54M
Diluted EPS (ttm)-1.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)96.69M
Total cash per share (mrq)0.26
Total debt (mrq)204.86M
Total debt/equity (mrq)13.38
Current ratio (mrq)2.19
Book value per share (mrq)4.07

Cash flow statement

Operating cash flow (ttm)27.57M
Levered free cash flow (ttm)-5.59M